Package Leaflet: Information for the User
Plavix 300 mg Film-Coated Tablets
clopidogrel
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Plavix contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that help it to clot. Antiplatelet agents prevent platelet clumping, reducing the risk of blood clots (a process called thrombosis).
Plavix is given to adults to prevent blood clots (thrombi) in blood vessels (arteries) that have become hardened, a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, myocardial infarction, or death).
You have been prescribed Plavix to help prevent blood clots and reduce the risk of these serious events because:
Do not take Plavix
If you think any of these apply to you, or if you are unsure, consult your doctor before taking Plavix.
Warnings and precautions
Before starting treatment with Plavix, inform your doctor if you are in any of the following situations:
During treatment with Plavix:
Children and adolescents
This medicine should not be given to children as it is not effective.
Taking Plavix with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may affect the use of Plavix or vice versa.
You must specifically tell your doctor if you are taking:
If you have had severe chest pain (unstable angina or myocardial infarction), a transient ischemic attack, or a mild ischemic stroke, you may have been prescribed Plavix in combination with acetylsalicylic acid, a substance found in many medications used to relieve pain and reduce fever. An occasional dose of acetylsalicylic acid (not exceeding 1,000 mg in 24 hours) is not likely to cause any problems, but prolonged use in other circumstances should be discussed with your doctor.
Taking Plavix with food and drinks
Plavix can be taken with or without food.
Pregnancy and breastfeeding
It is preferable not to take this medicine during pregnancy.
If you are pregnant or think you may be pregnant, you should tell your doctor or pharmacist before taking Plavix. If you become pregnant while taking Plavix, you should consult your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.
You should not breastfeed while taking this medicine.
If you are breastfeeding or plan to breastfeed, you should inform your doctor before taking this medicine.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
It is unlikely that Plavix will affect your ability to drive or use machines.
Plavix contains lactose
If your doctor has told you that you have an intolerance to some sugars (e.g., lactose), you should consult him before taking this medicine.
Plavix also contains hydrogenated castor oil
This may cause stomach upset and diarrhea.
Follow exactly the instructions of administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose, even for patients with a condition called "atrial fibrillation" (an irregular heartbeat), is one 75 mg Plavix tablet per day, taken orally with or without food and at the same time each day.
If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe you 300 mg or 600 mg of Plavix (1 or 2 tablets of 300 mg or 4 or 8 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg Plavix tablet per day, as described above.
If you have experienced symptoms of a stroke that disappear within a short period (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe you 300 mg of Plavix (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment. After that, the recommended dose is one 75 mg Plavix tablet per day, as described above, with acetylsalicylic acid for 3 weeks. After that, your doctor will prescribe either Plavix alone or acetylsalicylic acid alone.
You should take Plavix for as long as your doctor continues to prescribe it.
If you take more Plavix than you should
Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Plavix can cause side effects, although not everybody gets them.
Contact your doctor immediately if you experience:
The most common side effect reported with Plavix is bleeding. Bleeding may occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding from the blood vessels of the eyes, intracranial, pulmonary, or joint bleeding have also been reported.
If you experience prolonged bleeding while taking Plavix
If you cut or injure yourself, bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").
Other side effects include:
Common side effects (may affect up to 1 in 10 people):
Diarrhea, abdominal pain, indigestion, or heartburn.
Uncommon side effects (may affect up to 1 in 100 people):
Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in stomach or intestine, rash, itching, dizziness, tingling, and numbness.
Rare side effects (may affect up to 1 in 1,000 people):
Dizziness, breast enlargement in men.
Very rare side effects (may affect up to 1 in 10,000 people):
Jaundice; severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., general feeling of heat with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin; skin allergy; inflammation of the mouth mucosa (stomatitis); low blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.
Side effects with unknown frequency (cannot be estimated from the available data): Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar.
Additionally, your doctor may observe changes in the results of your blood or urine tests.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister, after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice any visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Plavix
The active ingredient is clopidogrel. Each tablet contains 300 mg of clopidogrel (as hydrogen sulfate).
The other components are (see section 2 "Plavix contains lactose" and "Plavix contains hydrogenated castor oil"):
Appearance of the Product and Package Contents
Plavix 300 mg film-coated tablets are oblong, pink, and engraved with the number "300" on one side and the number "1332" on the other. Plavix is available in cardboard boxes of 4x1, 10x1, 30x1, and 100x1 tablets in aluminum/aluminum unit-dose blisters.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing authorization holder:
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France
Manufacturer:
Sanofi Winthrop Industrie
1, Rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex, France.
For more information about this medicinal product, please contact the local representative of the marketing authorization holder.
Belgium/Belgique/Belgien Sanofi Belgium Tel: +32 (0)2 710 54 00 | Luxembourg/Luxemburg Sanofi Belgium Tel: +32 (0)2 710 54 00 (Belgium/Belgien) |
Bulgaria Swixx Biopharma EOOD Tel: +359 (0)2 4942 480 | Hungary SANOFI-AVENTIS Zrt Tel: +36 1 505 0050 |
Czech Republic sanofi-aventis, s.r.o. Tel: +420 233 086 111 | Malta Sanofi S.r.l. Tel: +39 02 39394275 |
Denmark Sanofi A/S Tlf: +45 45 16 70 00 | Netherlands Sanofi B.V. Tel: +31 20 245 4000 |
Germany Sanofi-Aventis Deutschland GmbH Tel: 0800 52 52 010 Tel from abroad: +49 69 305 21 131 | Norway sanofi-aventis Norge AS Tlf: +47 67 10 71 00 |
Estonia Swixx Biopharma OÜ Tel: +372 640 10 30 | Austria sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
Greece Sanofi-Aventis Μονοπρ?σωπη AEBE Tel: +30 210 900 16 00 | Poland sanofi-aventis Sp. z o.o. Tel: +48 22 280 00 00 |
Spain sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Portugal Sanofi - Produtos Farmacêuticos, Lda. Tel: +351 21 35 89 400 |
France Sanofi Winthrop Industrie Tel: 0 800 222 555 Call from abroad: +33 1 57 63 23 23 Croatia Swixx Biopharma d.o.o. Tel: +385 1 2078 500 | Romania Sanofi Romania SRL Tel: +40 (0) 21 317 31 36 |
Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenia Swixx Biopharma d.o.o. Tel: +386 1 235 51 00 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovak Republic Swixx Biopharma s.r.o. Tel: +421 2 208 33 600 |
Italy Sanofi S.r.l. Tel: 800 536 389 | Finland Sanofi Oy Tel: +358 (0) 201 200 300 |
Cyprus C.A. Papaellinas Ltd. Tel: +357 22 741741 | Sweden Sanofi AB Tel: +46 (0)8 634 50 00 |
Latvia Swixx Biopharma SIA Tel: +371 6 616 47 50 | United Kingdom (Northern Ireland) sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2525 |
Lithuania Swixx Biopharma UAB Tel: +370 5 236 91 40 |
Date of Last Revision of this Leaflet:
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/